After medical studies and residency in Lausanne, Francis Munier obtained board certification in both Ophthalmology and Medical Genetics. From 1991 to 1993, he received additional training at Children’s Hospital Los-Angeles with Linn-Murphree. His team contributed to extend the frontiers of retinoblastoma conservative management, notably by introducing techniques for intravitreal and intracameral chemotherapy. He was elected honorary secretary of ISOO in 2017, and president of ISGEDR in 2019. He is presently honorary professor and consultant at Jules-Gonin Eye Hospital, which has become a quaternary reference center, recruiting 50-60 new retinoblastoma patients yearly from 75 nations. He published 300 peer-reviewed papers (H-index=60).
Francis Munier
Switzerland
